EE586 Cost-Utility of Cladribine Tablets and Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis From the Societal Perspective in Spain
Abstract
Authors
R Ginestal O Duran C Rubio Terrés D Rubio-Rodríguez H De Los Santos C Ordoñez I Sánchez